Cargando…
Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID‐19 patients
We propose a new hypothesis that the established drug pentoxifylline deserves attention as a potential repurposed therapeutic for COVID‐19. Pentoxifylline is an immunomodulator with anti‐inflammatory properties. It is a nonselective phosphodiesterase inhibitor and through Adenosine A2A Receptor‐medi...
Autores principales: | Hendry, Bruce M., Stafford, Nina, Arnold, Ahran D., Sangwaiya, Arvind, Manglam, Vijay, Rosen, Stuart D., Arnold, Jayantha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383088/ https://www.ncbi.nlm.nih.gov/pubmed/32715661 http://dx.doi.org/10.1002/prp2.631 |
Ejemplares similares
-
Acute Appendagitis Presenting with Features of Appendicitis: Value of Abdominal CT Evaluation
por: Dubb, Sukhpreet, et al.
Publicado: (2008) -
Prohepcidin Levels in Refractory Anaemia Caused by Lead Poisoning
por: Arnold, Jayantha, et al.
Publicado: (2008) -
Capsule Endoscopy in the Diagnosis, Disease Mapping, and Monitoring of Treatment Response in Gastrointestinal Whipple's Disease
por: Davenport, Emily, et al.
Publicado: (2022) -
Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the Burden of the Cytokine Storm
por: Feret, Wiktoria, et al.
Publicado: (2021) -
Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update
por: Chen, Yung-Ming, et al.
Publicado: (2017)